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Murine γδ17 cells, which are T cells that bear the γδ T cell receptor (TCRγδ) and secrete 
interleukin-17A (IL-17A), are generated in the thymus and are critical for various immune 
responses. Although strong TCRγδ signals are required for the development of interferon-γ 
(IFN-γ)-secreting γδ cells (γδIFN cells), the generation of γδ17 cells requires weaker TCRγδ 
signaling. Here, we demonstrated that constrained activation of the kinase Syk downstream of 
TCRγδ was required for the thymic development of γδ17 cells. Increasing or decreasing Syk 
activity by stimulating TCRγδ or inhibiting Syk, respectively, substantially reduced γδ17 cell 
numbers. This delimited Syk activity optimally engaged the phosphoinositide 3-kinase (PI3K)-
Akt signaling pathway, which maintained the expression of master regulators of the IL-17 
program, RORγt and c-Maf. Inhibition of PI3K not only abrogated γδ17 cell development, but 
also augmented the development of a distinct, previously undescribed subset of γδ T cells. 
These CD8+Ly6a+ γδ T cells had a type-I interferon gene expression signature and expanded in 
response to stimulation with IFN-b. Collectively, these studies elucidate how weaker TCRγδ 
signaling engages distinct signaling pathways to specify the γδ17 cell fate and identifies a role for 





T cells bearing T cell receptors (TCRs) composed of γ and δ chains, γδ T cells, respond rapidly 
to an array of pathogens that includes human immunodeficiency virus (HIV) [1], influenza 
viruses [2], malaria parasites [3] and Mycobacterium tuberculosis [4]. Moreover, they are 
implicated in immunopathologies such as psoriasis [5] and multiple sclerosis [6] and possess 
anti-tumour properties [7]. Instrumental to this early involvement in host defense is their 
production of cytokines that mediate direct effector functions and help instruct appropriate 
downstream activation of adaptive lymphocytes. For example, γδ T cell–associated cytotoxic 
and anti-tumour responses correlate with secretion of interferon γ (IFNγ) [8], whereas secretion 
of interleukin 17A (IL-17A) orchestrates coordinated engagement of immune responses to 
bacterial and fungal infections [9, 10].  
Unlike αβ T cells, which adopt cytokine-secreting effector functions only when required to 
participate in ongoing immune responses, γδ T cells instead commit to subsequent effector fate 
(the secretion of IL-17 or IFNγ) during their development in the thymus [11, 12]. γδ T cells are 
thought to diverge from a common (αβ/γδ) thymocyte progenitor at the early CD4-CD8- “double 
negative” (DN) stage of differentiation, instructed by strong (akin to TCR cross-linking) TCR 
signaling from recently rearranged and expressed TCRγδ complexes [13-15]. It is at this point 
that γδ progenitors commit to subsequent effector fate, although the mechanisms that drive this 
process are not fully understood. 
We and others have provided clear evidence that thymic TCRγδ signaling plays a central role in 
determining γδ T cell effector fate [16-22]. A consistent message from these studies is that 
strong TCRγδ signals drive γδ progenitors toward an IFNγ-secreting (γδIFN) fate but are 
prohibitive for development of IL-17–committed γδ T (γδ17) cells. This presents an obvious 
conundrum: How do γδ17 cells develop if the strong TCRγδ signals required for DN thymocyte 
commitment to the γδ lineage are subsequently prohibitive to their generation? Our ongoing 
work seeks to address this key issue by exploring the differential signaling inputs that govern 
the development of the γδ17 and γδIFN cell lineages. Indeed, to this end we have demonstrated 
that engagement of the extracellular signal–regulated kinase (ERK) mitogen-activated protein 
kinase (MAPK) pathway downstream of TCRγδ favoured the development of γδIFN cells but not 
γδ17 cells [20]. 
Here, we demonstrated that TCRγδ-associated activity of the tyrosine kinase Syk is necessary 
to engage the phosphoinositide 3-kinase (PI3K) and Akt signaling pathway to facilitate γδ17 cell 
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development in mice. Crucially, however, this requirement for Syk is constrained, because 
either an increase or a decrease in Syk activity attenuated the generation of γδ17 cells. In the 
absence of appropriate Syk-PI3K-Akt signaling, expression of key master regulator genes of the 
IL-17 program, such as Rorc and Maf, was significantly reduced on a per-cell basis. Impairment 
of PI3K signaling in γδ progenitors also resulted in the unanticipated adoption of a type-I 
interferon gene signature that identifies a previously unknown innate-like CD8+Ly6a+ γδ T cell 
subset. Collectively, these data mechanistically link the requirement for “weak” TCRγδ signaling 
to a distinct signaling modality for generation of γδ17 cells, and identify a novel role for type-I 




Development of gd17 cells requires constrained Syk activity 
Although our previous work had shown that strong signaling through TCRγδ is not compatible 
with thymic development of γδ17 cells [20], the extent to which TCRγδ signaling pathways are 
actually required for generation of γδ17 cells remained unclear. All TCR signaling requires 
proximal tyrosine kinase activity to initiate signal transduction. Thus, we assessed by flow 
cytometry the presence of the kinases Lck, Zap70, and Syk in developing γδ progenitors from 
wild-type (WT) embryonic day 15 (E15) thymic lobes that had been allowed to develop for 7 
days in fetal thymic organ culture (FTOC). FTOC faithfully reproduces T cell development in 
vitro [23] and is ideal for studying the perinatal development of γδ T cells, in which early CD24+ 
(γδ24+) progenitors progress to a CD24-CD44-CD45RB- triple-negative (γδTN) stage before either 
becoming CD45RB+ (γδRB cells) — and in some cases then also CD44+ (γδIFN cells) — in an 
IFNγ-secreting developmental pathway, or becoming CD44+CD45RB- (γδ17 cells) in an IL-17–
secreting developmental pathway (fig. S1) [20].  
Intracellular flow cytometry revealed that both Lck and Zap70 were present at only low levels in 
γδ24+ progenitors (Fig. 1A). By contrast, Syk abundance was highest in γδ24+ cells. The presence 
of Syk and Zap70 was not strictly mutually exclusive (fig. S2A), but was similar between all gd T 
cell subsets expressing distinct TCRg-chain variable regions (Vγ) that were tested (fig. S2B). 
These data are consistent with previous reports that Syk is a dominant kinase at the β-selection 
checkpoint [24], whereas Zap70 dominates in mature peripheral cells. We confirmed this in 
splenic γδ T cells in which only Zap70, but not Syk, was present (fig. S2C). Phosphorylated Syk 
was detected in all thymic γδ cell subsets but was particularly evident in cells of the IFNg 
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developmental pathway, consistent with these cells receiving stronger TCRγδ signals than do 
γδ17 cells (fig. S2D). 
Because Syk appears to be the dominant TCR downstream tyrosine kinase in early γδ 
progenitors, we next assessed whether some amount of Syk activity (and by inference TCRγδ 
signaling), was necessary for γδ17 cell development by placing WT E15 thymic lobes in 7-day 
FTOC in the presence of increasing concentrations of the Syk inhibitor BAY-61-3606 [25], which 
reduces Syk phosphorylation in a dose-dependent manner (Fig. 1B). Compared to control 
conditions, inhibition of Syk resulted in a marked decrease in the generation of γδ17 cells (Fig. 
1C). Under conditions of partial Syk blockade (0.4µM BAY-61-3606), increased signaling 
through TCRγδ, induced by the addition of the activating TCRδ-specific antibody GL3, rescued 
the generation of γδ17 cells (Fig. 1D, and fig. S2E), revealing an antagonistic relationship 
between Syk inhibition and TCRγδ stimulation. Nonetheless, as the concentration of GL3 was 
increased, thereby stimulating more TCRγδ signaling, the generation of γδ17 cells was again 
markedly reduced (Fig. 1D). Thus, these data suggest that delimited Syk activity is required for 
efficient generation of γδ17 cells from γδ progenitors. 
 
Generation of gd17 cells requires PI3K activity  
We next considered that this delimited Syk activity must activate a distinct downstream signaling 
pathway to promote γδ17 cell development. A likely candidate was the PI3K pathway, because 
PI3Kδ-deficient mice had previously been reported to be resistant to psoriasis induction due to 
the absence of γδ17 cells [26]. To investigate, we assessed peripheral γδ T cell compartments in 
PI3Kδ-deficient (p110d-/-) animals. Adult p110d-/- mice had significantly reduced numbers of γδ17 
cells in peripheral lymph nodes (LN) compared to controls (Fig. 2A and fig. S3). To assess 
thymic development, E15 thymic lobes from PI3Kδ-deficient animals were cultured in FTOC for 
7 days. Consistent with the reduced number of γδ17 cells in the LNs of PI3Kδ-deficient mice, 
thymic lobes from these animals generated substantially fewer γδ17 cells than did WT controls 
(Fig. 2B), and this reduction in cell number was not a consequence of altered proliferation (fig. 
S4A) or apoptosis (fig. S4B). Culturing thymic lobes from p110d-/- embryos for 14 days to allow 
for the generation of both g-chain variable region 6 (Vγ6+)-expressing γδ17 cells, which develop in 
an initial wave, and the subsequent development of Vγ6- γδ17 cells, demonstrated that all γδ17 
subsets, regardless of Vγ-usage, required PI3Kδ for efficient development (Fig. 2C). This 
requirement for PI3Kδ was cell-intrinsic, because E15 thymocytes purified from PI3Kδ-deficient 
animals showed comparable developmental defects when cultured on PI3K-sufficent OP9-DL1 
stromal cells [27] (Fig. 2D).  
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The class I family of PI3K consists of four members: the class Ia PI3Kα, PI3Kβ, and PI3Kδ, and 
the class Ib PI3Kγ [28]. Specific inhibitors of PI3Kα, PI3Kβ, or PI3Kγ had marginal effects on γδ 
T cell development in E15 7-day FTOC of WT thymic lobes (fig. S5A). By contrast, specific 
inhibition of PI3Kδ or pan-inhibition of all class I PI3Ks recapitulated the significant reduction of 
γδ17 cell development observed in E15 FTOC of thymic lobes from p110d-/- mice (fig. S5, A and 
B). Inhibition of Akt (also called protein kinase B), a major downstream target of PI3K, also 
strongly reduced γδ17 cell generation (Fig. 2E). The use of FTOC additionally allowed for 
pharmacological inhibition of phosphatase and tensin homolog (PTEN),  which negatively 
regulates PI3K activity [28]. As expected, PTEN inhibition in 7-day FTOC of WT thymic lobes 
resulted in a significant increase in the development of γδ17 cells (Fig. 2F). Consistent with this, 
7-day FTOC of E15 thymic lobes from p110δE1020K knock-in mice, which have an activating 
mutation in the p110 catalytic subunit of PI3Kδ [29], also generated significantly increased 
numbers of γδ17 cells (Fig. 2G). This was also reflected in increased numbers of γδ17 cells in 
peripheral lymph nodes of adult p110dE1020K mice compared to littermate controls (Fig. 2H). 
Thus, activation of the PI3K signaling pathway is a key requirement for thymic development of 
all γδ17 cell subsets. 
 
TCRgd-associated Syk activity engages PI3K signaling 
We next explored the relationship between TCR-associated Syk activity and the activation of 
PI3K signaling, both of which were required for development of γδ17 cells. To do this, we treated 
E15 thymic lobes from WT embryos with inhibitors of either PI3K or Syk for 1 day and then 
harvested, fixed, and assessed γδ T cells for intracellular phosphorylated Akt (pAkt) as a 
readout of activation of the PI3K pathway. As expected, PI3K blockade resulted in reduced pAkt 
compared to controls (Fig. 3A). A reduction in pAkt was also observed in γδ progenitors in 
thymic lobes treated with Syk inhibitor (Fig. 3A), suggesting that Syk activity is required for 
activation of the PI3K-Akt pathway.  
These data suggested a model in which constrained TCRγδ-associated Syk activity stimulates 
PI3K for optimal development of γδ17 cells. Such a model predicts that increasing Syk activity 
above this optimal range, for example by TCRγδ stimulation with GL3, would not rescue partial 
inhibition of PI3K but would instead augment PI3K inhibition. To test this, we placed WT thymic 
lobes in 7-day FTOC with partial PI3K inhibition (0.25µM ZSTK474, the pan-PI3K inhibitor) and 
increasing concentrations of GL3. Note that partial inhibition of PI3K resulted in a significant 
reduction in the generation of γδ17 cells but did not block it completely (fig. S5B). As predicted, 
increased TCRγδ signaling exacerbated PI3K-mediated inhibition of γδ17 cell development to the 
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point that the generation of these cells effectively ceased completely (Fig. 3B). This synergistic 
effect was also observed in 7-day FTOC of p110d-/- thymic lobes treated with increasing 
concentrations of GL3 (fig. S6).  
This model also predicts that direct activation of PI3K should overcome the negative effects of 
Syk blockade on γδ17 cell development. To test this, we added the PTEN inhibitor SF1670, 
which indirectly activates PI3K, to 7-day FTOC of WT thymic lobes in the presence of partial 
Syk inhibition. As predicted, addition of the PTEN inhibitor rescued γδ17 cell development in the 
presence of the Syk inhibitor (Fig. 3C). Moreover, PTEN inhibition also rescued the generation 
of γδ17 cells in the presence of the TCRδ-activating antibody GL3 (Fig. 3D), demonstrating that 
augmented PI3K activity overrides the negative effects on γδ17 cell development of manipulating 
Syk activity, either positively or negatively, beyond an optimal range. These data suggested that 
greater TCRγδ-associated Syk activity, such as that induced by GL3 (Fig. 3E), may also reduce 
PI3K activation. Consistent with this, a small but significant reduction in PI3K-AKT activity, as 
indicated by a reduction in ribosomal protein S6 phosphorylation (pS6), in gd24+ cells was 
observed in response to GL3 (Fig. 3F). However, this GL3-induced decrease in PI3K-AKT 
activity was less than that observed when we inhibited Syk (Fig. 3F). Thus, the effect of 
increased Syk activity on reduced γδ17 cell development may also be through mechanisms 
independent of the observed reduction in PI3K signaling. Indeed, we have previously shown 
that TCRγδ-mediated ERK activation inhibits γδ17 cell development [20]. However, inhibition of 
ERK, which would normally increase gd17 cell number [20], did not rescue gd17 cell development 
in the presence of PI3K or Syk inhibition (Fig. 3G). This highlights the importance of the Syk-
PI3K axis, because, although increased PI3K activity can overcome the inhibitory effect of 
TCRgd-mediated ERK activation on gd17 cell development (Fig. 3D), the reverse is not true: ERK 
inhibition cannot overcome a deficit in Syk-PI3K signaling. 
The activation of PI3K is also associated with cytokine signaling [30]. γδ17 cells express both the 
IL-1 receptor (IL-1R) and the IL-7 receptor (IL-7R) (fig. S7A), and expand considerably in 
absolute number when either IL-1β or IL-7 are added to 7-day FTOC of WT thymic lobes (fig. 
S7B) [31]. Thus, we assessed whether IL-1β or IL-7 could activate PI3K in the context of γδ17 
cell development. Given that a PTEN inhibition–induced increase of PI3K activity rescued the 
generation of γδ17 cells in the presence of Syk blockade (Fig. 3C), we assessed whether the 
addition of either IL-1β or IL-7 could also increase PI3K activity to rescue γδ17 cell development 
under conditions of Syk inhibition. However, the addition of IL-1β or IL-7 to 7-day FTOC of WT 
thymic lobes in the presence of partial Syk blockade failed to significantly increase the 
generation of γδ17 cells (Fig. 3H), suggesting that neither IL-1β nor IL-7 were capable of 
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stimulating PI3K activity downstream of Syk. Collectively, these data are consistent with a 
model in which delimited TCRγδ-associated Syk activity can optimally activate PI3K-Akt 
signaling to promote thymic γδ17 cell development. 
 
PI3K inhibition reveals a distinct γδ T cell transcriptional program  
To further interrogate the role of PI3K signaling in early γδ T cell development, we next 
assessed gene expression, using single-cell RNA sequencing (scRNA-seq), in γδ progenitors 
that had developed in 8-day FTOC of WT E15 thymic lobes in the presence or absence of PI3K 
inhibition (Fig. 4A). We found that gd T cells from PI3K inhibitor–treated FTOC predominantly 
clustered separately from their control counterparts (Fig. 4A). Expression of Il2ra (CD25), 
Cd24a, Cd44, Cd27, Klrb1c (NK1.1), and Il2rb (CD122), plus assessment of Vγ-usage, allowed 
demarcation of γδ17 cells, γδIFN cells, and a grouping of more immature subsets consisting of 
γδ24+, γδTN, and γδRB cells (fig. S8, A to C). The expression of genes associated with an IL-17–
secreting program, such as Maf, Rorc, Blk, Il23r, and Sox13, further confirmed the γδ17 cluster 
(Fig. 4B). As shown above, the development of γδ progenitors along the IL-17 developmental 
pathway was substantially reduced in the presence of PI3K inhibition (Fig. 4A). Gene 
expression analysis of PI3K inhibitor–treated γδ T cells that did segregate with untreated γδ17 
cells showed markedly reduced expression of genes known to associate with a γδ17-specific 
signature, such as Cd163l1 (Scart1), Blk, Maf, and Sox13 [32] (Fig. 4C).  
We also observed expansion of γδRB cells (and to some extent γδTN cells) in 7-day FTOC of WT 
thymic lobes treated with PI3K inhibitor (Fig. 4A), which was also evident in 7-day FTOC of 
thymic lobes from p110d-/- mice (Fig. 2B), and in adult PI3Kd-deficient mice (fig. S3). These 
expanded cells displayed an expression signature characterised by increased expression of 
host defense genes (Fig. 4D and fig. S8D). Gene ontology and enrichment pathway analysis 
using Metascape [33] showed that this signature was heavily enriched for genes associated with 
interferon signaling, particularly type-I interferon signaling (Fig. 4E). A feature of this signature 
was an increase in expression of both Cd8b1 and Ly6a (Fig 4D). Analysis of single cells from 
untreated 8-day FTOC of WT thymic lobes revealed two clusters (#2 and #6) in which Cd8b1 
and Ly6a expression was evident (Fig. 4F). Cells of cluster #6 displayed the prominent 
interferon signaling signature (fig. S8E), whereas those in cluster #2 displayed features of 
thymically-derived innate T cells (fig. S8F) [34]. CD8β+Ly6a+ γδ T cells were readily identified by 
flow cytometry from WT thymic lobes and expanded in response to IFN-β treatment in 7-day 
FTOC (Fig. 4G) or inhibition of PI3K in 5-day FTOC (fig. S8G). Moreover, under conditions of 
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PI3K inhibition, non-gd17 cells made significantly more IFNg compared to similar cells from 
untreated lobes, consistent with a more innate-like phenotype (fig. S8H).  
The importance of this heretofore unreported γδ T cell–associated type-I interferon gene 
signature and the expansion of a previously undescribed innate-like CD8β+Ly6a+ γδ T cell 
subset in the presence of IFN-β, both of which were suppressed by PI3K-Akt signaling, will 
require further investigation and lies outside the scope of the current study. Nonetheless, the 
increase in cells exhibiting such a profile upon PI3K inhibition may be linked to increased activity 
of the transcription factor Foxo1, because PI3K signaling negatively regulates Foxo1 by 
facilitating its nuclear export and degradation [35]. Consistent with this, imagestream analysis of 
gdIFN cells from PI3K inhibitor–treated thymic lobes showed increased nuclear localization of 
Foxo1 and significant increase in expression of Foxo1 target genes, such as Sell (CD62L), Klf2, 
S1pr1, and Ccr7 (fig. S9, A to C). In addition, IL-7Ra, which is critical for appropriate γδ T cell 
development and is a well-characterized target of Foxo1 transcriptional activity, showed a 
significant increase in abundance on non-gd17 cells from PI3K inhibitor–treated lobes (fig. S9D). 
Notably, treatment of WT lobes with either Syk inhibitor or GL3, both of which we propose push 
Syk activity beyond an optimal range for gd17 cell development, also increased IL-7Ra on non-
gd17 cells (fig. S9D), further supporting a link between constrained TCRγδ-associated Syk 
activity and the PI3K-Akt pathway in developing γδ progenitors. 
 
Impairment of Syk-PI3K signaling attenuates expression of RORgt and c-Maf in 
developing gd progenitors 
The scRNA-seq data suggested that a mechanism by which PI3K inhibition might lead to 
decreased generation of gd17 cells was through reduced expression of key master regulator 
genes of the IL-17-program, such as Rorc and Maf, both of which are highly expressed in gd17 
cells (Fig. 4B and fig. S10, A and B) [17, 36]. To confirm, E15 thymic lobes from Rorc(gt)+/GFP 
mice, which express green fluorescent protein (GFP) from the RAR-related orphan receptor 
gamma-t (RORgt) promoter were cultured for 6 days in the presence or absence of PI3K 
inhibitor. Inhibition of PI3K reduced the frequency of RORgt+ gd24+/TN progenitors (Fig. 5A), and 
the RORgt+ gd24+/TN progenitors that were present had much lower amounts of RORgt on a per-
cell basis when PI3K signaling was impaired (Fig. 5A). A similar significant reduction in RORgt 
in gd24+/TN progenitors was also observed when E15 thymic lobes from Rorc(gt)+/GFP mice were 
cultured with either Syk inhibitor (Fig. 5B), or activating antibody GL3 (Fig. 5C), which reduce or 
increase proximal TCRgd–associated Syk activity, respectively. The abundance of c-Maf was 
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also assessed under these conditions. Similar to RORgt, the frequency of c-Maf+ gd24+/TN 
progenitors, and the amount of c-Maf on a per-cell basis were both significantly reduced when 
WT E15 thymic lobes were cultured in the presence of PI3K inhibitor, Syk inhibitor, or GL3 
antibody (Fig. 5D). Collectively, these data suggest that constrained TCRgd-associated Syk 
activity is required to activate the PI3K-Akt pathway in early gd progenitors to maintain the 
expression of key master regulator transcription factors associated with IL-17 secretion and 
establishment of a gd17 cell fate. 
 
DISCUSSION 
Consensus suggests that to enter the γδ T cell lineage DN thymocytes must express a surface T 
cell receptor complex with the capacity to transduce a “strong” TCR signal [13-15]. Essentially 
this is mediated by TCRγδ that, by nature of its high surface abundance, signals at significantly 
higher amounts than does the competing preTCR (pTα paired with TCRβ) that instead instructs 
DN progenitors toward the αβ T cell lineage. After entering the γδ lineage, thymic γδ progenitors 
further commit to subsequent effector fate, mainly to express either IFNγ or IL-17. TCRγδ signal 
strength is implicated here too, with strong TCRγδ signaling promoting an IFNγ-secreting fate 
and only weaker TCRγδ signaling being compatible with the generation of γδ17 cells [16-20]. 
However, the signaling modalities that manifest these weaker TCRγδ signals and the conceptual 
challenge of explaining the paradoxical requirement for both strong (to commit to the lineage) 
and weak (to commit to effector function) TCRγδ signals to adopt a γδ17 cell fate, have remained 
essentially unresolved. 
 
This study begins to address these issues. We demonstrated that constrained activity of the 
TCR-proximal kinase Syk was required for γδ17 cell development. Syk inhibition or increased 
TCRγδ signaling acted antagonistically to decrease or increase, respectively, Syk activity 
beyond an optimal range for the generation of γδ17 cells. Optimal Syk activity, in turn, engaged 
the PI3K-Akt pathway that is necessary for appropriate maintenance of the IL-17-secreting 
program master regulators, RORγt and c-Maf. These data directly contradict a previous study 
that suggested a positive correlation between TCRγδ stimulation, Syk phosphorylation, and 
PI3K activation in thymic γδ progenitors [37]. Such a model would predict that TCRγδ stimulation 
(such as with the activating antibody GL3) should rescue partial pharmacological inhibition of 
PI3K for the development of γδ17 cells. However, our data demonstrate exactly the opposite, 
with the combination of TCRγδ stimulation and partial PI3K inhibition instead being additive and 
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negative. Indeed, our findings explain how “weaker” TCRγδ signaling translates to distinct 
signaling modalities that permit certain γδ progenitors to adopt the γδ17 cell fate.  
 
These findings have important implications for the nature of γδ17-associated TCRs – specifically, 
that characteristics of γδ17-associated TCRs must restrict TCR signaling to permit Syk-mediated 
engagement of PI3K-Akt signaling that promotes a γδ17 cell phenotype. An obvious modulator of 
TCR signaling is TCR-ligand engagement. For example, increased signaling mediated by a 
Skint1-associated TCR-ligand for the Vγ5Vδ1+TCR has been implicated in the development of 
Vγ5+ progenitors along the CD45RB+ IFNγ-pathway [18]. Moreover, in KN6 transgenic mice 
(which express a single Vγ4Vδ5+TCR), on a recombination-activating gene (RAG)-deficient 
background, thymic provision of the high-affinity ligand H2-T22 (an MHC class-Ib molecule) 
promotes γδIFN cell development, whereas presence of the lower affinity ligand H2-T10 permits 
some generation of γδ17 cells, possibly through assistance from Notch signaling and cytokines 
such as IL-1β, IL-21 and IL-23 [21, 38]. Nonetheless, in the absence of identified ligands for the 
vast majority of murine TCRγδ, other explanations for TCR signal modulation must also be 
considered [12]. Thus, a constrained TCRγδ signal strength may also be a consequence of 
certain TCRγ-TCRδ pairings that do not allow the formation of fully signaling-competent TCR-
CD3 complexes. Alternatively, factors that are co-expressed in the perinatal period, during 
which all γδ17 cells develop [39], may interact with certain TCRγδ to constrain signaling. Possible 
candidates for these putative signal-modulating factors could be members of the group B 
scavenger receptor cysteine-rich (SRCR) family of proteins. These include SCART1 (CD163L1) 
and SCART2 (5830411N06Rik) that are predominantly expressed on Vγ6+ and Vγ4+ γδ17 cells, 
respectively [32, 40]. Notably, the SRCR family WC1 proteins, which are closely related to 
SCART1 and SCART2, are known to form complexes with TCRγδ on bovine γδ T cells [41]. 
These interactions appear to alter the signaling capacities of the TCR by providing additional 
intracellular docking sites for kinase binding. Thus, it is conceivable that comparable interactions 
between γδ17-associated TCRs and SCART1 or SCART2 may modulate intracellular signaling to 
promote Syk-PI3K-Akt–mediated γδ17 cell development, an idea that we are currently exploring.  
 
A modulated or constrained TCRγδ signal that permits engagement of Syk-PI3K-Akt to promote 
γδ17 cell development does not in itself satisfactorily address the paradoxical requirement for a 
“weaker-signaling” γδ17-associated TCRγδ to have first signalled strongly enough to commit a 
DN progenitor to the γδ lineage [12]. This raises the intriguing possibility that distinct γδ17 
progenitors might exist that possess different developmental potentials compared with the 
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conventional DN progenitors that enter either the ab or γδIFN lineages as a consequence of 
weaker or stronger signaling, respectively, at the b-selection checkpoint [42]. Thus, constrained 
TCRγδ signaling that engages the Syk-PI3K-Akt pathway in a putative γδ17 progenitor would be 
compatible with continued development toward a γδ17 cell phenotype that shares many 
similarities with RORγt+ type 3 innate lymphoid cells (ILC3) and especially lymphoid tissue 
inducer (LTi) cells [43, 44]. By contrast, stronger conventional TCRγδ signaling that also 
engages alternative downstream signaling pathways, such as ERK, may be incompatible with 
the continued development of these alternative γδ17 progenitors [20]. 
 
The possible existence of separate γδ17 progenitors is supported by studies from two groups. 
Shibata and colleagues suggested that although γδIFN cells could be generated (like ab T cells) 
from both DN2 and DN3 thymocyte progenitors, γδ17 cells could develop only from c-kithi DN2 
cells [45]. Similarly, a prior report from the Kang group had also suggested that c-kit+ “early 
thymic progenitors” were a source of γδ17 cells, but were restricted to generating only the Vγ4+ 
subset [46]. Unlike other γδ17 subsets, Vγ4+ γδ17 cells appear to require Sox4 and Sox13 for 
development [46, 47]. Moreover, the transcriptional signature of immature CD24+Vγ4+ cells 
segregated from other immature γδ T cell subsets in a principle components analysis of 
microarray-derived transcriptomic data [46]. Somewhat surprisingly, a follow-up study re-
characterized the putative Vγ4+ γδ17 progenitors as c-kit- (rather than c-kit+), CD24+ DN1 (DN1d) 
cells that were also Sox13+ (so-called “Soxpro” cells) [48]. These Soxpro cells already 
expressed genes associated with a γδ17 cell program, such as Maf, Rorc, and Blk. They also 
appeared to favour initiation of Vγ4-targeted TCRγ chain rearrangements and developed as 
Vγ4+ γδ17 cells when placed in thymic organ culture. Notably however, this study also 
demonstrated that TCRγδ was still required for differentiation of Soxpro cells into Vγ4+ γδ17 cells, 
because DN1d cells (including Soxpro cells) accumulated in TCRδ-deficient mice, and DN1d 
cells from KN6 transgenic mice generated more Vγ4+ γδ17 cells than did control DN1d cells, 
suggesting that in-frame Vγ4+ TCR rearrangements are normally limiting in the latter. Our data 
here suggest that this TCRγδ requirement would equate to constrained TCRγδ-associated Syk 
activity that allows engagement of PI3K-Akt signaling to support the development of γδ17 
progenitors to a mature γδ17 cell phenotype. Our findings would also assert that increased 
TCRγδ signal strength in this Vγ4+ γδ17 progenitor, for example in the presence of the activating 




Although compelling, the focus on a pre-committed progenitor for Vγ4+ γδ17 cells somewhat 
ignores the developmental origins of other γδ17 cells, especially the Vγ6+ γδ17 cells that are 
generated in a first wave of T cell development alongside Vγ5+ dendritic epidermal T cell 
(DETC) progenitors, and that populate diverse body sites such as the female reproductive tract, 
dermis, and peritoneal and oral cavities [12]. Our data suggest that all γδ17 subsets, regardless 
of Vγ-usage, require constrained TCR-mediated Syk activity to activate the PI3K-Akt pathway. 
Thus, all γδ17 subsets may derive from separate precursors that are distinct from conventional 
ab/γδIFN progenitors. 
Finally, an unanticipated finding from these studies was that inhibition of PI3K signaling in 
developing γδ progenitors induced a robust type-I interferon gene signature, particularly in cells 
of the IFNγ-secreting developmental pathway. This signature has not been previously reported 
in γδ T cells and clearly warrants further in-depth investigation. Type-I interferons are expressed 
in the thymus [49], in which they are suggested to regulate the maturation of conventional ab T 
cells [50]. Thymic type-I interferons have also been suggested to drive development of innate 
unconventional memory-like CD44+CD8+ T cells in an Eomesodermin-dependent manner [34]. 
We observed that addition of type-I interferons to WT FTOC promoted the generation of a 
population of CD8+ γδ T cells that additionally express Ly6a. Further investigation is underway to 
understand the functional potential of these cells and their relationship to other innate-like T cell 
subsets that are also generated in the thymus. 
 
The importance of type-I interferon signaling to γδ T cell function is not well documented. 
However, studies have reported expansion of IL-17–secreting γδ17 cells in type-I interferon 
receptor (IFNAR) knockout mice both in response to Francisella tularensis and Listeria 
monocytogenes infections [51] and in a model of secondary Streptococcus pneumoniae 
infection after influenza infection [52]. At least some of the effect of type-I interferon on γδ17 cells 
was direct, possibly through decreasing the expression of Rorc [51]. Nonetheless, there may 
also be indirect effects through the production of IL-27, which suppresses IL-17 secretion by γδ17 
cells [51]. Moreover, type-I interferons are also reported to inhibit the production of IL-1b [53], 
which is required for expansion of γδ17 cells. Notably, type-I interferons have been reported to 
have anti-inflammatory properties in autoimmune disease settings, in which IL-17-associated 
immune responses tend to dominate. Thus, a better understanding of how PI3K signaling 
regulates the responsiveness to type-I interferons in developing γδ T cells may provide critical 
insight into the opposing functions of pro-inflammatory IL-17–driven antibacterial immunity and 
innate type-I interferon–driven antiviral responses.  
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MATERIALS AND METHODS 
Mice  
C57BL/6 wild-type (WT) mice were purchased from Charles River Laboratories. PI3Kδ-deficient 
mice (p110d-/-) [54] and PI3Kδ-hyperactive mice (p110dE1020K) [29] were kindly provided by Prof 
K Okkenhaug (Cambridge, UK). Rorc(gt)+/GFP reporter mice [55] were kindly provided by Dr G 
Eberl (Pasteur Institute, Paris). All strains were on a C57BL/6 background. Mice were foetal 
(E15-E17), neonatal (3-4 days) or adult females (4-12 weeks). Embryos were from timed 
pregnancies. Mice were bred and maintained in specific pathogen-free animal facilities at 
Queen Mary University of London or relevant facility. All experiments involving animals were 
performed in full compliance with UK Home Office regulations and institutional guidelines. 
 
Foetal Thymic Organ Cultures (FTOC) 
Foetal thymic lobes from WT, p110d-/-, p110dE1020K, or Rorc(gt)+/GFP mice were cultured on 
nucleopore membrane filter discs (Whatman) in complete medium (RPMI-1640 with 10% FCS, 
1% penicillin and streptomycin, 50 µM b-mercaptoethanol, and 2 mM L-glutamine) for indicated 
length of time (hours or days). In some experiments the following antibody (eBioscience), 
inhibitors (Selleckchem), or recombinant cytokines were added to the cultures (concentrations 
indicated): TCRd-specific antibody GL3, pan-Akt inhibitor MK-2206, MEK1/2 inhibitor UO126 
(Sigma-Aldrich), pan-PI3K inhibitor ZSTK474, p110a inhibitor A66, p110b inhibitor TGX-221, 
p110d inhibitor IC87114, p110g inhibitor AS605240, PTEN inhibitor SF1670, Syk inhibitor BAY-
61-3606, interleukin-1b (IL-1b; R&D), IL-7 (Peprotech) and IFN-b (Peprotech). Cultures 
containing antibody or inhibitors were rested overnight in fresh complete medium before 
analysis, unless otherwise indicated. All thymic organ cultures were subsequently analysed by 
flow cytometry. 
 
Tissue processing and cell isolation 
Single-cell suspensions of foetal and neonatal thymocytes were obtained by gently 
homogenizing thymic lobes followed by straining through a 30 µm nylon gauze (Sefar Ltd., UK). 
To obtain single-cell suspensions of lymphocytes, adult peripheral lymph nodes (axillary, 
inguinal and brachial) and spleens were teased apart, followed by filtering through an 80 µm 
stainless steel mesh (Sefar Ltd., UK) in fluorescence-activated cell sorting (FACS) buffer 
[phosphate-buffered saline (PBS) containing 2% heat-inactivated foetal calf serum (FCS; 
Invitrogen) and 5 mM ethylenediaminetetraacetic acid (EDTA; Invitrogen)]. Erythrocytes from 
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splenic samples were osmotically lysed in ACK lysis buffer (Invitrogen) and cells washed twice 
in FACS buffer. 
 
Cell culture 
OP9-DL1 cells (kindly provided by J.C Zúniga-Pflücker, Sunnybrook Research Institute, 
Toronto) [27] were maintained at 75% confluency in Dulbecco’s modified Eagles’ medium 
(DMEM) with GlutaMAX (Invitrogen), 10% FCS, 1% penicillin and streptomycin, 50 µM β-
mercaptoethanol (Invitrogen), and 1% non-essential amino acids (Invitrogen) at 37°C and 5% 
CO2. Foetal thymocytes from WT or p110d-/- E15 thymic lobes were isolated and seeded onto a 
semi-confluent monolayer of OP9-DL1 cells cultured in flat-bottom 96-well plates with 200 µl of 
complete DMEM medium supplemented with 5 ng/ml Flt3 ligand (Miltenyi Biotec) and 1 ng/ml 
IL-7 (Miltenyi Biotec). IL-7 and Flt3 ligand were replenished every 3 days. Cells were cultured 
for 8 days at 37°C and 5% CO2, followed by analysis by flow cytometry. 
 
Flow cytometry 
Fluorochrome-conjugated antibodies (purchased from eBioscience, BD, Biolegend or Cell 
Signaling Technology, unless otherwise indicated) against the following cell surface and 
intracellular molecules were used: rabbit Ig Alexa-488, rabbit Ig Alexa-647, rat IgM (RM-7B4), 
Annexin V, Blk, CD3e (145-2C11), CD8a (53-6.7), CD8b (H35-17.2), CD24 (M1/69), CD44 
(IM7), CD45RB (C363.16A), CD121a (IL-1Ra; JAMA-147), CD127 (IL-7Ra; SB/199), c-Maf 
(sym0F1), Foxo1 (C29H4), IFNg (XMG1.2), IL-17A (eBio17B7), Lck (73A5), Ly6A/E (Sca-1; D7), 
pAkt (Ser473; D9E), pSyk (pY348; I120-722), pS6 (Ser235/236; D57.2.2E), RORgt (B2D), TCRd 
(GL3), Vg1 (2.11), Vg4 (UC3-10A6), Vg5 (536), Vg7 (F2.67; kindly provided by Dr Pablo Pereira, 
Pasteur Institute, Paris), Syk (5F5), Zap70 (1E7.2), and 17D1 (kindly provided by Prof Adrian 
Hayday, Francis Crick Institute, London). For cell surface staining, thymocytes and lymphocytes 
were incubated on ice with CD16/CD32-specific antibodies (2.4G2; eBioscience) to block Fc 
receptors and stained with fluorochrome-conjugated antibodies diluted in FACS buffer. 
Detection of both Vg5Vd1 and Vg6Vd1 with 17D1 was performed as previously described [20]. 
After staining, cells were washed and re-suspended in FACS buffer. 4',6-diamidino-2-
phenylindole (DAPI; Invitrogen), DRAQ7™ (Biolegend) or Zombie Aqua™ Fixable Viability dye 
(Biolegend) were used for dead cell exclusion prior to analysis. For detection of intracellular 
molecules, cells were stained for surface markers and Zombie Aqua™ Fixable Viability dye 
(Biolegend) for dead cell exclusion, fixed with IC fixation buffer (eBioscience) for 15 min on ice 
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and subsequently permeabilized and stained with intracellular antibodies diluted in 
permeabilization buffer (eBioscience). For intracellular cytokine staining, cells were stimulated, 
prior to staining, with 50 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma) and 1 µg/ml 
ionomycin (Sigma) for 4h at 37°C; 10 µg/ml Brefeldin A (eBioscience) and 2µM Monensin 
(eBioscience) were added during the last 2 h. For intracellular detection of pAkt, pSyk, or pS6, 
thymic lobes were collected directly in chilled tubes containing fluorochrome-conjugated 
antibody staining mix and immediately homogenised to release thymocytes. After a 10-min 
incubation on ice for cell surface marker staining, cells were fixed with IC fixation buffer for 15 
min on ice. For intracellular detection of transcription factors or Ki67, cells were fixed and 
permeabilised with the Foxp3/Transcription Factor buffer set (eBioscience) as per the 
manufacturer’s instructions and subsequently stained with fluorochrome-conjugated antibodies. 
Samples were acquired using an LSR-II flow cytometer (BD) or Canto II (BD) and data were 
analysed using FlowJo software (Tree Star, Inc.). 
 
Imagestream analysis  
Thymic gd T cells from 7-day FTOC were enriched by depleting CD4+ cells using magnetic-
activated cell sorting (MACS), according to the manufacturer’s instructions (Miltenyi Biotec). 
Briefly, cells were surface stained with biotin-conjugated anti-CD4 antibody (RM4.4; 
eBioscience) and subsequently labelled with anti-biotin microbeads (Miltenyi Biotec). Labelled 
cells were magnetically sorted and the flow-through was retained for cell surface and 
intracellular staining. Cells were resuspended in FACS buffer and nuclei were stained with DAPI 
just prior to sample acquisition using the Imagestream multispectral imaging flow cytometer 
(Amnis). Corresponding images were analysed using the IDEAS software after single in-focus 
cells were selected based on a gating strategy using gradient RMS and area versus aspect 
ratio. 
 
Cell sorting and generation of single cell RNA-seq libraries 
Thymocytes from WT E15 thymic lobes cultured for 8 days in the presence or absence of pan-
PI3K inhibitor ZSTK474 (0.25 µM) were isolated and stained for cell surface molecules as 
described above, and total gd T cells were sorted on a FACSAria (BD). Sorted cells were 
depleted of non-viable cells by low density gradient centrifugation. Viable cells were collected, 
counted and diluted to 1000 cells/µl. Single cell sequencing libraries were generated using the 
Chromium™ Single Cell 5’ Library and Gel Bead Kit (10X Genomics) according to the 
manufacturer’s instructions. Briefly, following the capture and lysis of single cells, cDNA was 
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synthesised, amplified and uniquely indexed libraries were pooled for sequencing (Illumina 
NextSeq). 
 
Analysis of single-cell RNA-seq data 
Analyses of RNA-seq data was carried out in R v3 using the package Seurat v2.3 [56]. Quality 
control measures were undertaken to obtain high-quality data for further analysis by filtering out 
cells with a gene number less than 200 or more than 3000, cells with more than 20% 
mitochondrial genes, and genes expressed in less than 3 cells. Datasets from control and pan-
PI3K inhibitor-treated samples were integrated for comparative analyses. Subsequently, highly 
variable genes were defined and scaled data was subjected to principal component analysis. 
Statistically significant principle components (PCs) were identified based on the JackStraw 
method and Elbow plot method implemented in Seurat. Unsupervised graph-based clustering 
was performed using significant PCs and clustering resolution of 0.8, and visualised using the 
non-linear dimensional reduction technique, t-distributed Stochastic Neighbor Embedding 
(tSNE). After clustering, differentially expressed genes defining each cluster as well as between 
samples within a single cluster were identified. Gene ontology and enrichment pathway analysis 
was performed using Metascape [33]. 
 
Statistical analysis  
Statistical analysis was performed using GraphPad Prism software. Data are presented as 
mean ± s.d. Student’s t-test or one-way analysis of variance (ANOVA) were used to assess 
statistical significance of differences between groups. A difference was considered significant if 




Figs. S1 to S10  
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Fig. 1. Development of gd17 cells requires constrained Syk activity. (A) Flow cytometry plots 
of gd T cells from WT E15 thymic lobes after 7-day FTOC showing total TCRd+ cells (gd+ cells) 
and CD24- gd (gd24-) T cells. Histograms show the abundance of Lck, Zap70, and Syk in the 
indicated gd T cell subsets. Summary graphs show mean fluorescence intensity (MFI) of Lck, 
Zap70, and Syk in the indicated gd T cell subsets. Data are representative of at least two 
independent experiments. Each symbol represents at least 4 thymic lobes pooled. (B) 
Histogram shows the abundance of phosphorylated Syk (pSyk) in CD24+ gd (gd24+) T cells from 
WT neonatal thymocytes treated with the indicated concentrations of the Syk inhibitor BAY-61-
3606 (BAY-61) or left untreated for 2h. Percentages of pSyk-positive cells are indicated. 
Summary graph shows the relative MFI of intracellular pSyk (n = 3 replicates per group, where 
each replicate represents 2 neonatal thymuses pooled). (C) Plots show gd24- T cells from WT 
E15 7-day FTOC in the absence or presence of the indicated concentrations of BAY-61-3606. 
Data are representative of two independent experiments. (D) Plots show gd24- T cells from WT 
E15 7-day FTOC in the absence or presence of the TCRd-activating antibody GL3 
(concentrations indicated) and BAY-61-3606 (0.4 µM). Summary graph shows absolute number 
of gd17 cells in each condition. Each symbol represents at least 2 thymic lobes pooled. 
Percentages of gated cells are indicated in plots. Error bars represent s.d. TN, triple negative for 





Fig. 2. Generation of gd17 cells requires PI3K activity. (A) Flow plots show gd24- T cells from 
lymph nodes (LN) of WT and p110d-/- mice to quantify gd17 (CD24-CD45RB-CD44+) cells. The 
gd17 cells were stimulated ex vivo with the T cell activators PMA and ionomycin for 4h before 
measuring IL-17 and IFNg. Summary graph shows absolute numbers of IL-17+ gd17 cells. Data 
are representative of three independent experiments (n ≥ 5 mice per group). (B) Plots show gd24- 
T cells from 7-day FTOC of E15 thymic lobes from WT or p110d-/- mice and IL-17 and IFNg	in	
gd17 cells after 3h PMA and ionomycin stimulation. Summary graphs show absolute number of 
gd17 cells and IL-17+ gd17 cells. Data are representative of six independent experiments. (C) Plots 
show gd24- T cells from 14-day FTOC of WT or p110d-/- E15 thymic lobes. Pie charts depict Vg-
usage by gd17 cells from the same cultures. Data are representative of two independent 
experiments. (D) Plots show gd24- T cells from 8-day co-culture of thymocytes isolated from WT 
or p110d-/- E15 thymic lobes with OP9-DL1 stromal cells. IL-17 and IFNg	was measured in	gd17 
cells from these cultures after 3h PMA and ionomycin stimulation. Summary graph shows 
percentage of gd17 cells from the cultures. Data are representative of two independent 
experiments. (E and F) Plots show gd24- T cells from 7-day FTOC of WT E15 thymic lobes in the 
presence or absence of the pan-Akt inhibitor MK-2206 (0.125 µM) (E) or the PTEN inhibitor 
SF1670 (2 µM) (F). (G) Plots show gd24- T cells from 7-day FTOC of p110dWT or p110dE1020K E15 
thymic lobes. Summary graphs show absolute number of gd17 cells in the cultures. Data are 
representative of two (E and G) or five (F) independent experiments. (H) Plots show gd24- T cells 
from lymph nodes of adult p110dWT and p110dE1020K mice and IL-17 and IFNg	in	gd17 cells after 
4h PMA and ionomycin stimulation. Summary graph shows absolute number of IL-17+ gd17 cells. 
Data are representative of two independent experiments (n = 5 mice per group). Percentages of 
gated cells and gd subset are indicated on plots. Each symbol represents an individual mouse or 
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at least four thymic lobes pooled. *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001 (Unpaired Student’s t-
test).  
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Fig. 3. Constrained TCRgd-associated Syk activity stimulates the PI3K pathway to 
generate gd17 cells. (A) Graph shows relative mean fluorescence intensity (MFI) of intracellular 
phosphorylated Akt (pAkt) in gd T cells from 1-day FTOC of WT E15 thymic lobes in the 
presence or absence of the pan-PI3K inhibitor ZSTK474 (pan-PI3K inh, 0.25 µM) or the Syk 
inhibitor BAY-61-3606 (Syk inh, 0.4 µM). Data are from three independent experiments (n = 10 
replicates per group, where each replicate represents at least 3 thymic lobes pooled). (B to D) 
Plots of gd24- T cells from 7-day FTOC of WT E15 thymic lobes in the presence or absence of 
GL3 (concentrations indicated) and/or the pan-PI3K inhibitor (0.25 µM) (B); in the presence of 
the indicated combinations of the Syk inhibitor (0.1 µM) and the PTEN inhibitor (2 µM) (C); and 
in the presence of the indicated combinations of GL3 (0.1 µg/ml), and the PTEN inhibitor (2 µM) 
(D). Data are representative of two independent experiments. (E and F) Graphs show relative 
MFI of intracellular pSyk (E) and phosphorylated S6 (pS6) (F) in gd24+ T cells from 4h FTOC of 
WT E15 thymic lobes in the presence or absence of GL3 (1 µg/ml) or the Syk inhibitor (0.4 µM) 
as indicated. Data are from one (E), or three (F) independent experiments (n = 3 to 8 replicates 
per group, where each replicate represents at least 2 thymic lobes pooled). (G and H) Plots of 
gd24- T cells from 7-day FTOC of WT E15 thymic lobes in the indicated combinations of the pan-
PI3K inhibitor (0.25 µM), the Syk inhibitor (0.4 µM), and the MEK inhibitor UO126 (5 µM) (G) or 
the indicated combinations of the Syk inhibitor (0.4 µM), IL-1b (5 ng/ml), and IL-7 (10 ng/ml) (H). 
Data are representative of two independent experiments. Summary graphs (C, D, G and H) 
show the absolute number of gd17 cells in the cultures. Each symbol represents at least four 
thymic lobes pooled. Percentages of gated cells and gd subset are indicated on plots. Error bars 
represent s.d.  *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001 (Unpaired Student’s t-test (E) or ANOVA 




Fig. 4. PI3K inhibition reveals a previously undescribed γδ T cell–associated 
transcriptional program. (A) Flow plots show gd24- T cells from 8-day FTOC of WT E15 thymic 
lobes in the presence or absence of the pan-PI3K inhibitor ZSTK474 (0.25 µM). The gd T cells 
from these organ cultures were used for scRNA-seq, the results of which are illustrated in the t-
SNE plot. Each dot represents a single cell. (B) t-SNE representations show expression of 
genes associated with the IL-17-secreting developmental program in control or PI3K-inhibited gd 
T cells. (C) Heatmap shows differentially expressed genes (DEGs) in gd17 cells from control 
versus PI3K-inhibited FTOC (adjusted P ≤ 0.05). (D) Heatmap illustrates the expression of the 
top 20 DEGs that increased within the indicated gd subsets in control or PI3K-inhibited FTOC 
(adjusted P ≤ 0.05). Each column is the expression profile of a single cell. (E) Metascape 
pathway analysis of DEGs that increased in gd17 cells from PI3K inhibitor–treated FTOC. Only 
the most enriched pathways are illustrated. (F) Large t-SNE representation shows gd T cells 
from untreated 8-day FTOC of WT E15 thymic lobes. Each dot represents a single cell, and 
each cluster is coloured and numbered. Smaller plots show expression of Cd8b1 and Ly6a. 
Demarcated clusters (dashed lines) correspond to a single or a group of gd subsets as 
indicated, or the expression of Cd8b1 and Ly6a. (G) Flow plots show gd T cells from 7-day 
FTOC of WT E15 thymic lobes in the presence or absence of IFN-b (200 U/ml). Summary graph 
shows absolute number of CD8b+ non-gd17 cells. Data are representative of two independent 
experiments. Each symbol represents at least 3 thymic lobes pooled. Percentages of gated cells 




Fig. 5. Impairment of Syk-PI3K signaling attenuates IL-17-program master-regulator 
genes in developing gd progenitors. (A to C) Plots of gd T cells from 6-day FTOC of E15 
thymic lobes from mice expressing GFP (RORgt) in the absence or presence of the pan-PI3K 
inhibitor ZSTK474 (0.25 µM) (A), the Syk inhibitor BAY-61-3606 (0.4 µM) (B), or GL3 (1 µg/ml) 
(C). For each treatment, the gd24+/TN subset of the total gd T cell population was further analysed 
for GFP expression plotted against side-scatter (SSC). Summary graphs show the percentage 
GFP+ cells in the gd24+/TN population and the mean fluorescence intensity (MFI) in GFP+ cells. (D) 
Plots of gd T cells from 6-day FTOC of WT E15 thymic lobes in the absence or presence of the 
pan-PI3K inhibitor (0.25 µM), the Syk inhibitor (0.4 µM), or GL3 (1 µg/ml). The gd24+/TN cells from 
the total gd T cell population were further analysed for c-Maf. Summary graphs show the 
percentage of c-Maf+ cells in the gd24+/TN population and the MFI of c-Maf in those cells. 
Percentages of gated cells and gd subset are indicated on plots. Data are representative of two 
independent experiments. Each symbol represents at least 4 thymic lobes pooled. *P ≤ 0.05, 
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Fig. S1. CD24, CD44, and CD45RB segregate IL-17–producing and IFNg–producing gd 
T cells. Plots of gd T cells from 7-day FTOC of WT E15 thymic lobes. gd24- T cells from left 
panel are further sub-divided by CD44 and CD45RB (middle panel). Right panel shows 
intracellular staining for IL-17 and IFNg in gdTN, gdRB, gdIFN and gd17 subsets after 3h 
stimulation ex vivo with PMA and ionomycin. Data are representative of at least three 




Fig. S2. Expression of Syk and Zap70 in thymic and peripheral gd T cell subsets. (A) Plots 
show expression of Syk and Zap70 in indicated gd T cell subsets from WT E15 thymic lobes 
after 7-day FTOC. Percentages of cells within each quadrant are indicated. Data are 
representative of three independent experiments. (B) Summary graphs show mean fluorescence 
intensity (MFI) of Zap70 and Syk in Vg-specific gd T cells, within indicated gd T cell subsets, 
from WT E15 thymic lobes after 8-day FTOC. (C) Plots of splenic gd T cells from adult WT 
mice showing intracellular expression of Syk or Zap70. Data are representative of two 
independent experiments. (D) Histograms show expression of TCRd and pSyk in indicated gd 
T cell subsets from WT E15 thymic lobes after 7-day FTOC. Summary graphs show MFI of 
TCRd and pSyk in indicated gd T cell subsets. (E) Summary graphs show absolute number of 
indicated gd T cell subsets from WT E15 7-day FTOC in the presence (or absence) of Syk 
inhibitor BAY-61-3606 (0.4 µM), and/or anti-TCRd antibody GL3 (1 µg/ml). Data are 
representative of two independent experiments. Each symbol represents at least 3 thymic lobes 




Fig. S3. gdRB cells expand in the absence of PI3K activity. Plots show gd24- T cells from WT 
and p110d-/- adult lymph nodes (LN). Summary graphs show absolute number of gdRB and gdIFN 
cells. Data are representative of three independent experiments (n ≥ 5 mice per group). ***P ≤ 





Fig. S4. Proliferation and apoptosis of thymic gd T cells in PI3Kd-deficient mice. (A) Plots 
show thymocytes from 4-day FTOC of WT or p110d-/- E15 thymic lobes. Percentages of gated 
cells are indicated on plots. Summary graph shows percentage of Ki67+ gd T cells (n = 3 
replicates per group, where each replicate represents 2 thymic lobes pooled). (B) Plots show gd 
T cells from 2-day FTOC of WT or p110d-/- E15 thymic lobes. Percentages of gated cells are 
indicated on plots. Summary graph shows percentage of apoptotic (Annexin V+) gd T cells (n 





Fig. S5. gd17 cell development requires PI3K activity. (A) Plots of gd24- T cells from 7-day 
FTOC of WT E15 thymic lobes in presence or absence of inhibitors (concentrations indicated) 
of PI3Ka (A66), PI3Kb (TGX-221), PI3Kg (AS605240), PI3Kd (IC8711), or pan-PI3K 
inhibitor (ZSTK474). Percentages of gated cells are indicated on plots. (B) Summary graph 
shows absolute number of gd17 cells from 7-day FTOC of WT E15 thymic lobes in presence or 
absence of a pan-PI3K inhibitor ZSTK474 (0.25 µM). Data are representative of two 
independent experiments. Each symbol represents at least 4 thymic lobes pooled. *P ≤ 0.05 





Fig. S6. TCRgd signalling exacerbates loss of PI3K for gd17 cell generation. Plots show gd24- 
T cells from 7-day FTOC of WT or p110d-/- E15 thymic lobes in the presence or absence of 
anti-TCRd antibody GL3 (concentrations indicated). Percentages of gated cells and gd subset 




Fig. S7. gd17 cells express elevated levels of IL-1R and IL-7Ra on their surface. (A) 
Histograms show expression of IL-1R and IL-7Ra on gdIFN (green) and gd17 cells (orange) from 
7-day FTOC of WT E16 thymic lobes. (B) Plots show gd24- T cells from 7-day FTOC of WT 
E15 thymic lobes in the presence or absence of IL-1b (5 ng/ml) or IL-7 (10 ng/ml). Percentages 
of gated cells and gd subset are indicated on plots. Summary graphs show absolute number of 
gd17 cells from associated cultures. Data are representative of two independent experiments. 




Fig. S8. Single-cell transcriptomic analysis of developing gd T cells. (A and B) t-SNE 
representations show expression of known markers (A) and TCR-Vg chains (B) used to identify 
distinct gd subsets, in integrated gd T cells from single-cell RNA-sequencing  performed on 
sorted gd T cells from 8-day FTOC of WT E15 thymic lobes in the presence or absence of pan-
PI3K inhibitor ZSTK474 (0.25 µM). (C) t-SNE visualisation coloured and numbered by cluster 
after un-supervised clustering. Each dot represents a single cell. Demarcation (dashed line) of 
clusters correspond to a single or a group of gd subsets as indicated. (D) t-SNE representations 
show expression of selected genes in control or PI3K inhibitor-treated gd T cells. (E and F) 
Heatmaps show differentially expressed genes (DEGs) between cluster 2 and cluster 6 gd T 
cells from untreated 8-day FTOC of WT E15 thymic lobes (adjusted P ≤ 0.05). (G) Plots show 
gd T cells from 5-day FTOC of WT E17 thymic lobes in the presence or absence of pan-PI3K 
inhibitor ZSTK474 (0.25 µM). Summary graph shows absolute number of CD8b+ non-gd17 
cells. Each symbol represents at least 3 thymic lobes pooled. (H) Left panels show gd T cells 
from 7-day FTOC of WT E15 thymic lobes in the presence or absence of pan-PI3K inhibitor 
ZSTK474 (0.25 µM). Right panels show intracellular staining for IL-17 and IFNg in non-gd17 
cells after 3h stimulation ex vivo with PMA and ionomycin. Summary graph shows absolute 
number of IFNg+ non-gd17 cells. Percentages of gated cells and gd subset are indicated on plots. 
Data are representative of one (A-G) or three (H) independent experiments. Each symbol 




Fig. S9. PI3K inhibition upregulates Foxo1 activity in gdIFN cells. (A) Imagestream analysis 
of gdIFN cells from 7-day FTOC of WT E15 thymic lobes in the presence or absence of pan-
PI3K inhibitor ZSTK474 (0.25 µM). Scale bar, 7 µm. (B) Summary graph shows total (left) 
and nuclear (right) Foxo1 intensity in gdIFN cells from experiments described in (A). Data are 
representative of two independent experiments. (C) t-SNE representations show expression of 
Foxo1 target genes in integrated visualisation of gd T cells from 8-day FTOC of WT E15 
thymic lobes in the presence or absence of pan-PI3K inhibitor ZSTK474 (0.25 µM). (D) 
Histograms (middle panels) show expression of IL-7Ra on non-gd17 cells (from left panel) 
from 6-day FTOC of RORgt-GFP+/- E15 thymic lobes in the absence or presence of pan-PI3K 
inhibitor ZSTK474 (0.25 µM), Syk inhibitor BAY61-3606 (0.4 µM), or GL3 (1 µg/ml). 
Summary graphs show MFI of IL-7Ra in non-gd17 cells from the different treatments. Data are 
representative of two independent experiments. Each symbol represents at least 4 thymic lobes 




Fig. S10. Expression of IL-17-associated transcription factors in distinct gd subsets. (A) 
Histograms show expression of c-Maf, RORgt and Blk in peripheral gdIFN and gd17 cells from 
spleen of adult WT mice. (B) Histogram shows expression of c-Maf in distinct gd subsets from 
6-day FTOC of WT E15 thymic lobes. gd subsets are indicated on the plots. Data are 
representative of two independent experiments. 
 
